跳至主要内容
临床试验/NCT05578105
NCT05578105招募中不适用

Prevalence and Genetic Alternation of Autoimmune Polyglandular Syndrome Type II in Taiwan

National Taiwan University Hospital1 个研究点 分布在 1 个国家目标入组 650 人开始时间: 2022年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
650
试验地点
1
主要终点
Rates of endocrine organs involved

研究概览

简要总结

Autoimmune polyendocrine syndrome (APS) is an autoimmune disease involving at least two endocrine organ. It is classified into type I and type II diseases. Among them, APS type II is more common. It is diagnosed when two of the three following diseases are diagnosed in the same patient, including type 1 diabetes mellitus, autoimmune thyroid disease, and primary adrenal insufficiency. In this study, we will observe the epidemiology, clinical characteristics, and genetic variants of APS II in Taiwan.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients visited NTUH during 2006-2021, and had at least two of the three diseases: type 1 DM, primary adrenal insufficiency, and autoimmune thyroid disease.

排除标准

  • Patients aged less than 20 years old

结局指标

主要结局

Rates of endocrine organs involved

时间窗: 2022/1/1 ~ 2026/12/31

We will observe the rate of each endocrine organ involved, including adrenal gland, thyroid, and pancreas

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验